Molecular imaging of gliomas with PET: opportunities and limitations.
about
Emerging methods for disease monitoring in malignant gliomasGetting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrierDW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastomaDynamic PET and Optical Imaging and Compartment Modeling using a Dual-labeled Cyclic RGD Peptide Probe.Evaluation of dynamic contrast-enhanced T1-weighted perfusion MRI in the differentiation of tumor recurrence from radiation necrosis.Treatment-related brain tumor imaging changes: So-called "pseudoprogression" vs. tumor progression: Review and future research opportunitiesDiagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testingComparison of magnetic resonance spectroscopy and positron emission tomography in detection of tumor recurrence in posttreatment of glioma: A diagnostic meta-analysis.Imaging mimics of primary malignant tumors of the central nervous system (CNS).Current status and future role of brain PET/MRI in clinical and research settings.Hybrid MR-PET in Neuroimaging.[Molecular imaging in neurological diseases].Facile synthesis of SSR180575 and discovery of 7-chloro-N,N,5-trimethyl-4-oxo-3(6-[(18)F]fluoropyridin-2-yl)-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide, a potent pyridazinoindole ligand for PET imaging of TSPO in cancer.(68)Ga-PRGD2 PET/CT in the evaluation of Glioma: a prospective study.Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivoProspective Study of (68)Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and First Application in Glioma Patients.Anticalins directed against the fibronectin extra domain B as diagnostic tracers for glioblastomas.Preclinical TSPO Ligand PET to Visualize Human Glioma Xenotransplants: A Preliminary Study(18)F-FDG PET-CT: a powerful tool for the diagnosis and treatment of relapsing polychondritis.Usefulness of FDG, MET and FLT-PET studies for the management of human gliomas.Potential role for magnetoencephalography in distinguishing low- and high-grade gliomas: a preliminary study with histopathological confirmation.Multi-modal imaging of tumor cellularity and Tryptophan metabolism in human Gliomas.Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies.Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1).Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.18F-fluorothymidine PET imaging in gliomas: an update.Tryptophan PET in pretreatment delineation of newly-diagnosed gliomas: MRI and histopathologic correlatesSplit-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness.Monitoring of Tumor Growth with [(18)F]-FET PET in a Mouse Model of Glioblastoma: SUV Measurements and Volumetric Approaches.Perfusion and diffusion MRI combined with ¹¹C-methionine PET in the preoperative evaluation of suspected adult low-grade gliomas.Imaging tumor burden in the brain with 89Zr-transferrinInterrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.Clinical use of (11)C-methionine and (18)F-FDG-PET for germinoma in central nervous system.Clinical aggressiveness of malignant gliomas is linked to augmented metabolism of amino acids.Technical Issues of [(18)F]FET-PET Imaging for Radiation Therapy Planning in Malignant Glioma Patients - A Review.Performance of 18F-FET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysis.The role of surgery in grade II/III oligodendroglial tumors.Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.Neurologic Applications of PET/MR Imaging.Molecular imaging and cancer gene therapy.
P2860
Q27023823-1A3793B1-14D2-4F15-A144-F8434D5D6445Q28071873-4C1DD570-D4E3-4472-B1A4-790C9723CAC9Q28730443-B3D15188-2A45-4088-865F-FD0CCEDF15ECQ30524330-AF7942AE-7DA6-44DF-BB6D-BD081B5C104DQ30582849-B51D87D7-0FB2-4792-9537-75AE559EEF1BQ30627773-5CB25188-3856-410D-9CCF-4AD9AEC80E07Q30810936-2BAEE3F2-874D-4777-84C5-58819E43AF44Q30811922-E98C5AF0-0486-49AE-ACE5-452BCCA54729Q30831008-289C249F-A6FC-4982-A891-1892E245AD63Q30883711-58B66BCF-6598-48DF-ACD9-6917DE3C7159Q30984050-F1C751C4-E510-48F6-AE49-F1D24C771366Q31108303-D84620A7-2357-4F25-AA39-466F044CDD4BQ34175347-957FE3DB-C190-4ED0-A056-A99C0B42FBB4Q34473605-33016E7D-7AB3-4038-961D-92698745FB61Q35606075-B366A504-C098-4D66-B431-818787695B5DQ35633357-470CE65D-315D-49F3-8ABE-CAAA04B18C53Q35793074-342E408D-15E3-4E70-8F25-166FDA498A42Q35827097-C78539E3-94FF-45FC-A6B1-5DE6A7B578CCQ35830495-9DB212BA-3F29-4C61-9EE8-40AB15FBCC9FQ35912078-0166C238-E5BF-426E-B861-04A96E600B11Q35914520-1B0ACC8A-F13A-4F78-A62B-190BA0194228Q35923158-F6A4B140-7A13-4427-9E1F-4726FBF862E4Q35927273-F290233A-073E-43EE-9F11-0351F46EAAA2Q36157048-4CFD0883-26A5-4194-9EF8-6F7D2A09CC6DQ36250739-7ACF9C8A-DC40-4176-B161-2402681F82B7Q36404866-4B1D7787-45A4-426B-82FE-A0D6DDE9F8C9Q36644371-ADD3EE6C-0A41-4E67-A924-6953C89F41F0Q36946481-7BC04CC6-E897-455F-87A3-5FFAA4564285Q37000245-59FE4583-F8B0-4E69-99C2-DF281912FB95Q37092483-AB11A55B-9F92-48DD-9249-F2051329A1E0Q37106244-CEC4A923-DB79-4D09-811C-2ABBD1A30224Q37236103-DC202F21-8E05-422A-B9B4-61C699F7A7D5Q37589387-C87CB53D-CAE2-48D3-A7E8-D12DCDFC5AD4Q37730054-55B0631A-F4DC-45D8-9DE0-CB41D60FAE5DQ38051641-1C6AFB5D-BE8D-42A3-9369-6DCCFAA8F5F4Q38561073-20BC8E23-F4F8-4AD0-8C4A-20E4DCC74680Q38610485-BDD61756-BBC0-4358-BC55-D1665DEFACDBQ38815396-59F276A9-C885-4A7D-A6F8-09650A3D628BQ38846608-EA4AA5D3-45A0-417D-89AC-A47017910B12Q39011437-72142D07-4033-49C1-B935-982ACA9C1071
P2860
Molecular imaging of gliomas with PET: opportunities and limitations.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Molecular imaging of gliomas with PET: opportunities and limitations.
@ast
Molecular imaging of gliomas with PET: opportunities and limitations.
@en
type
label
Molecular imaging of gliomas with PET: opportunities and limitations.
@ast
Molecular imaging of gliomas with PET: opportunities and limitations.
@en
prefLabel
Molecular imaging of gliomas with PET: opportunities and limitations.
@ast
Molecular imaging of gliomas with PET: opportunities and limitations.
@en
P2093
P2860
P50
P356
P1433
P1476
Molecular imaging of gliomas with PET: opportunities and limitations.
@en
P2093
Bogdana Suchorska
Christian la Fougère
Friedrich-Wilhelm Kreth
Peter Bartenstein
P2860
P304
P356
10.1093/NEUONC/NOR054
P577
2011-07-13T00:00:00Z